Skip to content
akaturk Academic measurement
Sign in Register

Academician

İREM KIRIŞ

DOKTOR ÖĞRETİM ÜYESİ

BAHÇEŞEHİR ÜNİVERSİTESİ TIP FAKÜLTESİ TEMEL TIP BİLİMLERİ BÖLÜMÜ

A quick look at recorded outputs — details below.

  • Articles 15
  • Projects 0
  • Books 0
  • Proceedings 0
  • Patents 0
  • Artistic 0
Scopus (SJR) Q1 9 Q2 6 Q3 0 Q4 0
WoS (JCR) Q1 3 Q2 6 Q3 6 Q4 0
TR Index 2 articles

Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.

Top 1% articles 0
Top 10% articles 2
Avg percentile 64.9%
Top 1% share 0.0%
Top 10% share 13.3%

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Index filters

15 publications total

Scopus (SJR)
Q1 9 Q2 6 Q3 0 Q4 0
WoS (JCR)
Q1 3 Q2 6 Q3 6 Q4 0
TR Index
2 articles

Article list

  1. 2025 Proteomic signatures and mitochondrial dysfunctions in peripheral T cells reveal novel ınsights into Alzheimer's disease SCIENTIFIC REPORTS DOI 10.1038/s41598-025-22783-9 YÖKSİS SJR Q1 JCR Q1 OpenAlex 81.5%
  2. 2024 O-demethyl Galantamine Alters Protein Expression in Cerebellum of 5xFAD Mice TURKISH JOURNAL OF BIOLOGY DOI 10.55730/1300-0152.2692 YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 4.6%
  3. 2024 O-demethyl Galantamine Alters Protein Expression in Cerebellum of 5xFAD Mice TURKISH JOURNAL OF BIOLOGY DOI 10.55730/1300-0152.2692 YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 4.6%
  4. 2023 Detection of proteomic alterations at different stages in a Huntington's disease mouse model via matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) imaging EUROPEAN JOURNAL OF NEUROSCIENCE DOI 10.1111/ejn.16103 YÖKSİS SJR Q2 JCR Q3 OpenAlex 54.1%
  5. 2023 Proteomic alterations in the cerebellum and hippocampus in an Alzheimer?s disease mouse model: Alleviating effect of palmatine BIOMEDICINE & PHARMACOTHERAPY DOI 10.1016/j.biopha.2022.114111 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 94.1%
  6. 2023 Detection of proteomic alterations at different stages in a Huntington's disease mouse model via matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) imaging EUROPEAN JOURNAL OF NEUROSCIENCE DOI 10.1111/ejn.16103 YÖKSİS SJR Q2 JCR Q3 OpenAlex 54.1%
  7. 2023 Proteomic alterations in the cerebellum and hippocampus in an Alzheimer?s disease mouse model: Alleviating effect of palmatine BIOMEDICINE & PHARMACOTHERAPY DOI 10.1016/j.biopha.2022.114111 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 94.1%
  8. 2022 Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer's Disease Mouse Model CURRENT MEDICINAL CHEMISTRY DOI 10.2174/0929867328666210827152914 YÖKSİS SJR Q1 JCR Q2 OpenAlex 90.0%
  9. 2022 Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer?s disease patients NEUROSCIENCE LETTERS DOI 10.1016/j.neulet.2022.136799 YÖKSİS SJR Q2 JCR Q3 OpenAlex 84.3%
  10. 2022 Spatial proteomic alterations detected via MALDI-MS imaging implicate neuronal loss in a Huntington's disease mouse (YAC128) brain MOLECULAR OMICS DOI 10.1039/d1mo00440a YÖKSİS SJR Q2 JCR Q3 OpenAlex 61.9%
  11. 2022 Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer's Disease Mouse Model CURRENT MEDICINAL CHEMISTRY DOI 10.2174/0929867328666210827152914 YÖKSİS SJR Q1 JCR Q2 OpenAlex 90.0%
  12. 2021 Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer's Disease in Mouse Model CURRENT MEDICINAL CHEMISTRY DOI 10.2174/0929867327999201116193126 YÖKSİS SJR Q1 JCR Q2 OpenAlex 66.2%
  13. 2021 Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer's Disease in Mouse Model CURRENT MEDICINAL CHEMISTRY DOI 10.2174/0929867327999201116193126 YÖKSİS SJR Q1 JCR Q2 OpenAlex 66.1%
  14. 2020 Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity Cancer Medicine DOI 10.1002/cam4.3223 YÖKSİS SJR Q1 JCR Q2 OpenAlex 63.9%
  15. 2020 Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity Wiley DOI 10.1002/cam4.3223 YÖKSİS SJR Q1 JCR Q2 OpenAlex 63.9%

Back to academicians